re: i want a seat around the table next to kellygi
Maybe SIE is the company that posters have talked about recently in regards to the testing of SLT's kits in Singapore and the other listed ASX company that is being looked at as well as SLT?? They would fit well together. Wishful thinking probably on my behalf. Over the past two days they have had two great announcements. Yesterday they announced they had received registration for their new Hep. B vaccine in Singapore, and today they announced their Indian Commercial Partnership with Shreya Biotech for their Insulin and Hep B vaccines.. The partnership further enhances the relationship between Shreya Bio and Ranbaxy Pharmaceuticals. Shreya is a privately owned company with annual sales of US$350 million. Ranbaxy is a publicly listed company on Indian and NSYE with sales of SG$450 million. See announcements for further details. Deals look very positive, and with a market cap around the $20 million mark, there could be a lot more appreciation in this stocks share price.
Noggie Read disclaimer below
SLT Price at posting:
0.0¢ Sentiment: None Disclosure: Held
